The Chemours Company
CC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $3 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $0 | $4 | $4 | $4 |
| Enterprise Value | $2 | $6 | $6 | $6 |
| Revenue | $1 | $2 | $1 | $1 |
| % Growth | -7.4% | 18.1% | -1.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 15.7% | 17.2% | 17.3% | 19.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.2% | 9.4% | 11.3% | 11% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 4% | -23.6% | -0.3% | -0.6% |
| EPS Diluted | 0.399 | -2.54 | -0.027 | -0.053 |
| % Growth | 115.7% | -9,413.1% | 50% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |